Verastem (VSTM) Current Deferred Revenue (2011 - 2023)
Verastem's (VSTM) quarterly Current Deferred Revenue came in at $327000.0 in Q4 2023, up 68.56% quarter-over-quarter from $194000.0 in Q1 2018.
Verastem (VSTM) Current Deferred Revenue (2011 - 2023) Analysis & Trends
Verastem's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $327000.0 for Q4 2023.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $327000.0 in Q4 2023; TTM through Dec 2023 was $327000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $327000.0, changed N/A from the prior year.
- Current Deferred Revenue rose to $327000.0 in Q4 2023 per VSTM's latest filing, from $194000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $327000.0 in Q4 2023 and bottomed at $327000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 327,000.00 |
| Mar 31, 2018 | 194,000.00 |
| Dec 31, 2017 | 190,000.00 |
| Sep 30, 2017 | 186,000.00 |
| Jun 30, 2017 | 81,000.00 |
| Mar 31, 2017 | 179,000.00 |
| Dec 31, 2016 | 527,000.00 |
| Sep 30, 2016 | 171,000.00 |
| Jun 30, 2016 | 167,000.00 |
| Mar 31, 2016 | 164,000.00 |
| Dec 31, 2015 | 160,000.00 |
| Sep 30, 2015 | 156,000.00 |
| Jun 30, 2015 | 152,000.00 |
| Mar 31, 2015 | 148,000.00 |
| Dec 31, 2014 | 144,000.00 |
| Sep 30, 2014 | 137,000.00 |
| Jun 30, 2014 | 72,000.00 |
| Mar 31, 2014 | 28,000.00 |
| Dec 31, 2013 | 38,000.00 |
| Sep 30, 2013 | 43,000.00 |